BackOrphazyme A/S Overview

Orphazyme A/S Accounts Payable

Track Orphazyme A/S's accounts payable ($1.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.76M
↓ 1.51% YoYΔ $-27000.00 vs prior year quarter

Peer average

Loading

Orphazyme A/S Accounts Payable History

Loading

Orphazyme A/S vs. peers: Accounts Payable Comparison

Loading

Orphazyme A/S Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Orphazyme A/S (ORPHY) FAQ

Orphazyme A/S (ORPHY) currently reports a accounts payable of $1.8M as of June 2024. That compares with $1.8M in the prior-year period — down 1.5% year over year. Use the charts on this page to explore Orphazyme A/S's accounts payable history and peer comparisons.

Orphazyme A/S's accounts payable decreased from $1.8M to $1.8M — a 1.5% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Orphazyme A/S reported $1.8M in accounts payable as of June 2024. That compares with $1.8M in the prior-year period — down 1.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Orphazyme A/S, and consider following ORPHY for alerts when major investors trade the stock.

Orphazyme A/S is classified in the Healthcare sector. On accounts payable, it currently shows $1.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ORPHY with unrelated industries.